Old and new glycopeptide antibiotics: Action and resistance

Antibiotics

Volumn 3, Issue 4, 2014, Pages 572-594

  Binda, Elisa ^a,b   Marinelli, Flavia ^a,b   Marcone, Giorgia Letizia ^a,b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b POLITECNICO DI MILANO   (Italy)

Author keywords

Dalbavancin; Glycopeptides; Nonomuraea sp. ATCC 39727; Resistance; Van genes

Indexed keywords

AVOPARCIN; BALHIMYCIN; DALBAVANCIN; ORITAVANCIN; PENICILLIN BINDING PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; RISTOCETIN; TEICOPLANIN; TELAVANCIN; VANCOMYCIN;

ACTINOBACTERIA; ACTINOPLANES TEICHOMYCETICUS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FOOD AND DRUG ADMINISTRATION; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; GRAM POSITIVE INFECTION; GROWTH INHIBITION; MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NONOMURAEA; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; STREPTOCOCCUS PNEUMONIAE; STREPTOMYCES COELICOLOR; STRUCTURE ACTIVITY RELATION; VAN OPERON GENE; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; VANHAX GENE;

NONOMURAEA SP. ATCC 39727;

EID: 84979847575     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics3040572     Document Type: Review

References (96)

1. Rossolini, G. M.; Arena, F.; Pollini, S. Novel infectious diseases and emerging gram-positive multiresistant pathogens in hospital and community acquired infections. In Antimicrobials; Marinelli, F., Genilloud, O., Eds.; Springer Verlag: Berlin Heidelberg, Germany, 2014.
2. Yim, G.; Thaker, M. N.; Koteva, K.; Wright, G. Glycopeptide antibiotic biosynthesis. J. Antibiot. (Tokyo) 2014, 67, 31-41.
3. Kahne, D.; Leimkuhler, C.; Lu, W.; Walsh, C. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 2005, 105, 425-448.
4. Jovetic, S.; Zhu, Y.; Marcone, G. L.; Marinelli, F.; Tramper, J. β-Lactam and glycopeptide antibiotics: First and last line of defense? Trends Biotechnol. 2010, 28, 596-604.
5. Marcone, G. L.; Marinelli, F. Glycopeptides: An old but up to date successful antibiotic class. In Antimicrobials; Marinelli, F., Genilloud, O., Eds.; Springer Verlag: Berlin Heidelberg, Germany, 2014.
6. James, R. C.; Pierce, J. G.; Okano, A.; Xie, J.; Boger, D. L. Redesign of glycopeptide antibiotics: Back to the future. ACS Chem. Biol. 2012, 7, 797-804.
7. Nicolaou, K. C.; Boddy, C. N.; Bräse, S.; Winssinger, N. Chemistry, biology, and medicine of the glycopeptide antibiotics. Angew. Chem. Int. Ed. Engl. 1999, 38, 2096-2152.
8. Thaker, M. N.; Wright, G. D. Opportunities for synthetic biology in antibiotics: Expanding glycopeptide chemical diversity. ACS Synth. Biol. 2012, doi: 10. 1021/sb300092n.
9. Kalan, L.; Perry, J.; Koteva, K.; Thaker, M.; Wright, G. Glycopeptide sulfation evades resistance. J. Bacteriol. 2013, 195, 167-171.
10. Banik, J. J.; Brady, S. F. Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary. Proc. Natl. Acad. Sci. USA 2008, 105, 17273-17277.
11. Banik, J. J.; Brady, S. F. Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr. Opin. Microbiol. 2010, 13, 603-609.
12. Owen, J. G.; Reddy, B. V.; Ternei, M. A.; Charlop-Powers, Z.; Calle, P. Y.; Kim, J. H.; Brady, S. F. Mapping gene clusters within arrayed metagenomic libraries to expand the structural diversity of biomedically relevant natural products. Proc. Natl. Acad. Sci. USA 2013, 110, 11797-11802.
13. Borghi, A.; Edwards, D.; Zerilli, L. F.; Lancini, G. C. Factors affecting the normal and branched-chain acyl moieties of teicoplanin components produced by Actinoplanes teichomyceticus. J. Gen. Microbiol. 1991, 137, 587-592.
14. Taurino, C.; Frattini, L.; Marcone, G. L.; Gastaldo, L.; Marinelli, F. Actinoplanes teichomyceticus ATCC 31121 as a cell factory for producing teicoplanin. Microb. Cell Fact. 2011, 10, e82.
15. Cooper, M. A.; Williams, D. H. Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium. Chem. Biol. 1999, 6, 891-899.
16. Van Bambeke, F. Glycopeptides and glycodepsipeptides in clinical development: A comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Curr. Opin. Investig. Drugs 2006, 7, 740-749.
17. Jeya, M.; Moon, H. J.; Lee, K. M.; Kim, I. W.; Lee, J. K. Glycopeptide antibiotics and their novel semi-synthetic derivatives. Curr. Pharm. Biotechnol. 2011, 12, 1194-1204.
18. Cynamon, M. H.; Granato, P. A. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Antimicrob. Agents Chemother. 1982, 21, 504-505.
19. Mackay, J. P.; Gerhard, U.; Beauregard, D. A.; Westwell, M. S.; Searle, M. S.; Williams, D. H. Glycopeptide antibiotic activity and the possible role of dimerization: A model for biological signaling. J. Am. Chem. Soc. 1994, 116, 4581-4590.
20. Ashford, P. A.; Bew, S. P. Recent advances in the synthesis of new glycopeptide antibiotics. Chem. Soc. Rev. 2012, 41, 957-978.
21. Zhanel, G. G.; Calic, D.; Schweizer, F.; Zelenitsky, S.; Adam, H.; Lagacé-Wiens, P. R.; Rubinstein, E.; Gin, A. S.; Hoban, D. J.; Karlowsky, J. A. New lipoglycopeptides: A comparative review of dalbavancin, oritavancin and telavancin. Drugs 2010, 70, 859-886.
22. Higgins, D. L.; Chang, R.; Debabov, D. V.; Leung, J.; Wu, T.; Krause, K. M.; Sandvik, E.; Hubbard, J. M.; Kaniga, K.; Schmidt, D. E.; et al. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2005, 49, 1127-1134.
23. U. S. Food and Drug Administration. Available online: http://www. fda. gov/(accessed on 23 October 2014).
24. Bouza, E.; Burillo, A. Oritavancin: A novel lipoglycopeptide active against gram-positive pathogens including multiresistant strains. Int. J. Antimicrob. Agents 2010, 36, 401-407.
25. Belley, A.; McKay, G. A.; Arhin, F. F.; Sarmiento, I.; Beaulieu, S.; Fadhil, I.; Parr, T. R.; Moeck, G. Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing. Antimicrob. Agents Chemother. 2010, 54, 5369-5371.
26. Goldstein, B. P.; Selva, E.; Gastaldo, L.; Berti, M.; Pallanza, R.; Ripamonti, F.; Ferrari, P.; Denaro, M.; Arioli, V.; Cassani, G. A40926, a new glycopeptide antibiotic with anti-Neisseria activity. Antimicrob. Agents Chemother. 1987, 31, 1961-1966.
27. Malabarba, A.; Ciabatti, R. Glycopeptide derivatives. Curr. Med. Chem. 2001, 8, 1759-1773.
28. Malabarba, A.; Goldstein, B. P. Origin, structure, and activity in vitro and in vivo of dalbavancin. J. Antimicrob. Chemother. 2005, 55, 15-20.
29. Billeter, M.; Zervos, M. J.; Chen, A. Y.; Dalovisio, J. R.; Kurukularatne, C. Dalbavancin: A novel once-weekly lipoglycopeptide antibiotic. Clin. Infect. Dis. 2008, 46, 577-583.
30. Treviño, J.; Bayón, C.; Ardá, A.; Marinelli, F.; Gandolfi, R.; Molinari, F.; Jimenez-Barbero, J.; Hernáiz, M. J. New insights into glycopeptide antibiotic binding to cell wall precursors using SPR and NMR spectroscopy. Chemistry 2014, 20, 7363-7372.
31. Derlot, R.; Duval, E. J.; Courvalin, P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 1988, 319, 157-161.
32. Arias, C. A.; Murray, B. E. The rise of the enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 2012, 10, 266-278.
33. Courvalin, P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 2006, 42, S25-S34.
34. Bugg, T. D.; Wright, G. D.; Dutka-Malen, S.; Arthur, M.; Courvalin, P.; Walsh, C. T. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 1991, 30, 10408-10415.
35. Lessard, I. A.; Healy, V. L.; Park, I. S.; Walsh, C. T. Determinants for differential effects on D-ala-D-lactate vs. D-ala-D-ala formation by the VanA ligase from vancomycin-resistant enterococci. Biochemistry 1999, 38, 14006-14022.
36. Arthur, M.; Reynolds, P.; Courvalin, P. Glycopeptide resistance in enterococci. Trends Microbiol. 1996, 4, 401-407.
37. Arthur, M.; Molinas, C.; Bugg, T. D.; Wright, G. D.; Walsh, C. T.; Courvalin, P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 1992, 36, 867-869.
38. Reynolds, P. E.; Depardieu, F.; Dutka-Malen, S.; Arthur, M.; Courvalin, P. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine. Mol. Microbiol. 1994, 13, 1065-1070.
39. Wu, Z.; Wright, G. D.; Walsh, C. T. Overexpression, purification, and characterization of VanX, a D, D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry 1995, 34, 2455-2463.
40. Arthur, M.; Depardieu, F.; Molinas, C.; Reynolds, P.; Courvalin, P. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995, 154, 87-92.
41. Arthur, M.; Depardieu, F.; Cabanié, L.; Reynolds, P.; Courvalin, P. Requirement of the VanY and VanX D, D-peptidases for glycopeptide resistance in enterococci. Mol. Microbiol. 1998, 30, 819-830.
42. Arthur, M.; Depardieu, F.; Gerbaud, G.; Galimand, M.; Leclercq, R.; Courvalin, P. The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of Tn1546 and related elements in the absence of induction. J. Bacteriol. 1997, 179, 97-106.
43. Arthur, M.; Depardieu, F.; Courvalin, P. Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococci. Microbiology 1999, 145, 1849-1858.
44. Arthur, M.; Quintiliani, R. Regulation of VanA-and VanB-type glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 2001, 45, 375-381.
45. Wright, G. D.; Holman, T. R.; Walsh, C. T. Purification and characterization of VanR and the cytosolic domain of VanS: A two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry 1993, 32, 5057-5063.
46. Healy, V. L.; Lessard, I. A.; Roper, D. I.; Knox, J. R.; Walsh, C. T. Vancomycin resistance in enterococci: Reprogramming of the D-ala-D-ala ligases in bacterial peptidoglycan biosynthesis. Chem. Biol. 2000, 7, R109-R119.
47. Koteva, K.; Hong, H. J.; Wang, X. D.; Nazi, I.; Hughes, D.; Naldrett, M. J.; Buttner, M. J.; Wright, G. D. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. Nat. Chem. Biol. 2010, 6, 327-329.
48. Hong, H. J.; Hutchings, M. I.; Buttner, M. J.; Biotechnology and Biological Sciences Research Council, U. K. Vancomycin resistance VanS/VanR two-component systems. Adv. Exp. Med. Biol. 2008, 631, 200-213.
49. Depardieu, F.; Podglajen, I.; Leclercq, R.; Collatz, E.; Courvalin, P. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 2007, 20, 79-114.
50. Billot-Klein, D.; Blanot, D.; Gutmann, L.; van Heijenoort, J. Association constants for the binding of vancomycin and teicoplanin to N-acetyl-D-alanyl-D-alanine and N-acetyl-D-alanyl-D-serine. Biochem. J. 1994, 304, 1021-1022.
51. Reynolds, P. E.; Courvalin, P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob. Agents Chemother. 2005, 49, 21-25.
52. Baptista, M.; Depardieu, F.; Reynolds, P.; Courvalin, P.; Arthur, M. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol. Microbiol. 1997, 25, 93-105.
53. Depardieu, F.; Kolbert, M.; Pruul, H.; Bell, J.; Courvalin, P. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 2004, 48, 3892-3904.
54. Boyd, D. A.; Willey, B. M.; Fawcett, D.; Gillani, N.; Mulvey, M. R. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-ala-D-ser gene cluster, VanL. Antimicrob. Agents Chemother. 2008, 52, 2667-2672.
55. Lebreton, F.; Depardieu, F.; Bourdon, N.; Fines-Guyon, M.; Berger, P.; Camiade, S.; Leclercq, R.; Courvalin, P.; Cattoir, V. D-Ala-D-ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 2011, 55, 4606-4612.
56. Xu, X.; Lin, D.; Yan, G.; Ye, X.; Wu, S.; Guo, Y.; Zhu, D.; Hu, F.; Zhang, Y.; Wang, F.; et al. VanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob. Agents Chemother. 2010, 54, 4643-4647.
57. Nomura, T.; Tanimoto, K.; Shibayama, K.; Arakawa, Y.; Fujimoto, S.; Ike, Y.; Tomita, H. Identification of VanN-type vancomycin resistance in an Enterococcus faecium isolate from chicken meat in Japan. Antimicrob. Agents Chemother. 2012, 56, 6389-6392.
58. Bartley, J. First case of VRSA identified in Michigan. Infect. Control Hosp. Epidemiol. 2002, 23, 480.
59. Weigel, L. M.; Clewell, D. B.; Gill, S. R.; Clark, N. C.; McDougal, L. K.; Flannagan, S. E.; Kolonay, J. F.; Shetty, J.; Killgore, G. E.; Tenover, F. C. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003, 302, 1569-1571.
60. Moravvej, Z.; Estaji, F.; Askari, E.; Solhjou, K.; Naderi Nasab, M.; Saadat, S. Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains. Int. J. Antimicrob. Agents 2013, 42, 370-371.
61. Rossi, F.; Diaz, L.; Wollam, A.; Panesso, D.; Zhou, Y.; Rincon, S.; Narechania, A.; Xing, G.; di Gioia, T. S.; Doi, A.; et al. Transferable vancomycin resistance in a community-associated MRSA lineage. N. Engl. J. Med. 2014, 370, 1524-1531.
62. Foucault, M. L.; Courvalin, P.; Grillot-Courvalin, C. Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53, 2354-2359.
63. Périchon, B.; Courvalin, P. VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2009, 53, 4580-4587.
64. Marinelli, F. Chapter 2. From microbial products to novel drugs that target a multitude of disease indications. Methods Enzymol. 2009, 458, 29-58.
65. Marinelli, F.; Marcone, G. Small molecules, microbial secondary metabolites. In Comprehensive Biotechnology, 2nd ed.; Moo-Young, M., Ed.; Elsevier: Amsterdam, The Netherlands, 2011; Volume 3, pp. 285-297.
66. Cundliffe, E.; Demain, A. L. Avoidance of suicide in antibiotic-producing microbes. J. Ind. Microbiol. Biotechnol. 2010, 37, 643-672.
67. Marshall, C. G.; Broadhead, G.; Leskiw, B. K.; Wright, G. D. D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB. Proc. Natl. Acad. Sci. USA 1997, 94, 6480-6483.
68. Marshall, C. G.; Lessard, I. A.; Park, I.; Wright, G. D. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 1998, 42, 2215-2220.
69. Sosio, M.; Kloosterman, H.; Bianchi, A.; de Vreugd, P.; Dijkhuizen, L.; Donadio, S. Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus. Microbiology 2004, 150, 95-102.
70. Li, T. L.; Huang, F.; Haydock, S. F.; Mironenko, T.; Leadlay, P. F.; Spencer, J. B. Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: Characterization of two glycosyltransferases and the key acyltransferase. Chem. Biol. 2004, 11, 107-119.
71. Schäberle, T. F.; Vollmer, W.; Frasch, H. J.; Hüttel, S.; Kulik, A.; Röttgen, M.; von Thaler, A. K.; Wohlleben, W.; Stegmann, E. Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina. Antimicrob. Agents Chemother. 2011, 55, 4283-4289.
72. Pootoolal, J.; Thomas, M. G.; Marshall, C. G.; Neu, J. M.; Hubbard, B. K.; Walsh, C. T.; Wright, G. D. Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc. Natl. Acad. Sci. USA 2002, 99, 8962-8967.
73. Hegde, S. S.; Shrader, T. E. Femabx family members are novel nonribosomal peptidyltransferases and important pathogen-specific drug targets. J. Biol. Chem. 2001, 276, 6998-7003.
74. Neu, J. M.; Wright, G. D. Inhibition of sporulation, glycopeptide antibiotic production and resistance in Streptomyces toyocaensis NRRL15009 by protein kinase inhibitors. FEMS Microbiol. Lett. 2001, 199, 15-20.
75. Serina, S.; Radice, F.; Maffioli, S.; Donadio, S.; Sosio, M. Glycopeptide resistance determinants from the teicoplanin producer Actinoplanes teichomyceticus. FEMS Microbiol. Lett. 2004, 240, 69-74.
76. Beltrametti, F.; Consolandi, A.; Carrano, L.; Bagatin, F.; Rossi, R.; Leoni, L.; Zennaro, E.; Selva, E.; Marinelli, F. Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by van gene homologue expression directing the synthesis of a modified cell wall peptidoglycan. Antimicrob. Agents Chemother. 2007, 51, 1135-1141.
77. Hutchings, M. I.; Hong, H. J.; Buttner, M. J. The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor. Mol. Microbiol. 2006, 59, 923-935.
78. Hong, H. J.; Hutchings, M. I.; Neu, J. M.; Wright, G. D.; Paget, M. S.; Buttner, M. J. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol. 2004, 52, 1107-1121.
79. Novotna, G.; Hill, C.; Vincent, K.; Liu, C.; Hong, H. J. A novel membrane protein, VanJ, conferring resistance to teicoplanin. Antimicrob. Agents Chemother. 2012, 56, 1784-1796.
80. Kwun, M. J.; Novotna, G.; Hesketh, A. R.; Hill, L.; Hong, H. J. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall. Antimicrob. Agents Chemother. 2013, 57, 4470-4480.
81. Marcone, G. L.; Beltrametti, F.; Binda, E.; Carrano, L.; Foulston, L.; Hesketh, A.; Bibb, M.; Marinelli, F. Novel mechanism of glycopeptide resistance in the A40926 producer Nonomuraea sp. ATCC 39727. Antimicrob. Agents Chemother. 2010, 54, 2465-2472.
82. Marcone, G. L.; Binda, E.; Carrano, L.; Bibb, M.; Marinelli, F. The relationship between glycopeptide production and resistance in the actinomycete Nonomuraea sp. ATCC 39727. Antimicrob. Agents Chemother. 2014, 58, doi: 10. 1128/AAC. 02626-14.
83. Hong, H. J.; Hutchings, M. I.; Hill, L. M.; Buttner, M. J. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 2005, 280, 13055-13061.
84. Bentley, S. D.; Chater, K. F.; Cerdeño-Tárraga, A. M.; Challis, G. L.; Thomson, N. R.; James, K. D.; Harris, D. E.; Quail, M. A.; Kieser, H.; Harper, D.; et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 2002, 417, 141-147.
85. Sosio, M.; Stinchi, S.; Beltrametti, F.; Lazzarini, A.; Donadio, S. The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by Nonomuraea species. Chem. Biol. 2003, 10, 541-549.
86. Hugonnet, J. E.; Haddache, N.; Veckerlé, C.; Dubost, L.; Marie, A.; Shikura, N.; Mainardi, J. L.; Rice, L. B.; Arthur, M. Peptidoglycan cross-linking in glycopeptide-resistant actinomycetales. Antimicrob. Agents Chemother. 2014, 58, 1749-1756.
87. Binda, E.; Marcone, G. L.; Pollegioni, L.; Marinelli, F. Characterization of VanY(n), a novel D, D-peptidase/D, D-carboxypeptidase involved in glycopeptide antibiotic resistance in Nonomuraea sp. ATCC 39727. FEBS J. 2012, 279, 3203-3213.
88. Binda, E.; Marcone, G. L.; Berini, F.; Pollegioni, L.; Marinelli, F. Streptomyces spp. as efficient expression system for a D, D-peptidase/D, D-carboxypeptidase involved in glycopeptide antibiotic resistance. BMC Biotechnol. 2013, 13, e24.
89. Wright, G. D.; Molinas, C.; Arthur, M.; Courvalin, P.; Walsh, C. T. Characterization of VanY, a D, D-carboxypeptidase from vancomycin-resistant Enterococcus faecium BM4147. Antimicrob. Agents Chemother. 1992, 36, 1514-1518.
90. Reynolds, P. E.; Arias, C. A.; Courvalin, P. Gene vanxyc encodes D, D-dipeptidase (VanX) and D, D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol. Microbiol. 1999, 34, 341-349.
91. Mainardi, J. L.; Villet, R.; Bugg, T. D.; Mayer, C.; Arthur, M. Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in gram-positive bacteria. FEMS Microbiol. Rev. 2008, 32, 386-408.
92. Meziane-Cherif, D.; Stogios, P. J.; Evdokimova, E.; Savchenko, A.; Courvalin, P. Structural basis for the evolution of vancomycin resistance D, D-peptidases. Proc. Natl. Acad. Sci. USA 2014, 111, 5872-5877.
93. Marcone, G. L.; Carrano, L.; Marinelli, F.; Beltrametti, F. Protoplast preparation and reversion to the normal filamentous growth in antibiotic-producing uncommon actinomycetes. J. Antibiot. (Tokyo) 2010, 63, 83-88.
94. Marcone, G. L.; Foulston, L.; Binda, E.; Marinelli, F.; Bibb, M.; Beltrametti, F. Methods for the genetic manipulation of Nonomuraea sp. ATCC 39727. J. Ind. Microbiol. Biotechnol. 2010, 37, 1097-1103.
95. Jeong, H.; Sim, Y. M.; Kim, H. J.; Lee, D. W.; Lim, S. K.; Lee, S. J. Genome sequence of the vancomycin-producing Amycolatopsis orientalis subsp. Orientalis strain KCTC 9412T. Genome Announc. 2013, 1, doi: 10. 1128/genomeA. 00408-13.
96. Thaker, M. N.; Wang, W.; Spanogiannopoulos, P.; Waglechner, N.; King, A. M.; Medina, R.; Wright, G. D. Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat. Biotechnol. 2013, 31, 922-927.